These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11397811)

  • 1. Conserved cysteine and tryptophan residues of the endothelin-converting enzyme-1 CXAW motif are critical for protein maturation and enzyme activity.
    MacLeod KJ; Fuller RS; Scholten JD; Ahn K
    J Biol Chem; 2001 Aug; 276(33):30608-14. PubMed ID: 11397811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modelling and site-directed mutagenesis of the active site of endothelin-converting enzyme.
    Sansom CE; Hoang MV; Turner AJ
    Protein Eng; 1998 Dec; 11(12):1235-41. PubMed ID: 9930673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homology modeling and site-directed mutagenesis to identify selective inhibitors of endothelin-converting enzyme-2.
    Gagnidze K; Sachchidanand ; Rozenfeld R; Mezei M; Zhou MM; Devi LA
    J Med Chem; 2008 Jun; 51(12):3378-87. PubMed ID: 18507370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenesis of Glu403 to Cys in rabbit neutral endopeptidase-24.11 (neprilysin) creates a disulphide-linked homodimer: analogy with endothelin-converting enzyme.
    Hoang MV; Sansom CE; Turner AJ
    Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):925-9. PubMed ID: 9581575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular modeling of the active site of endothelin-converting enzyme.
    Sansom CE; Hoang VM; Turner AJ
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S75-7. PubMed ID: 8587473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping the active site of endothelin-converting enzyme-1 through subsite specificity and mutagenesis studies: a comparison with neprilysin.
    Johnson GD; Swenson HR; Ramage R; Ahn K
    Arch Biochem Biophys; 2002 Feb; 398(2):240-8. PubMed ID: 11831855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The N-terminal segment of endothelin-converting enzyme (ECE)-1b contains a di-leucine motif that can redirect neprilysin to an intracellular compartment in Madin-Darby canine kidney (MDCK) cells.
    Cailler F; Zappulla JP; Boileau G; Crine P
    Biochem J; 1999 Jul; 341 ( Pt 1)(Pt 1):119-26. PubMed ID: 10377252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat endothelin-converting enzyme-1 forms a dimer through Cys412 with a similar catalytic mechanism and a distinct substrate binding mechanism compared with neutral endopeptidase-24.11.
    Shimada K; Takahashi M; Turner AJ; Tanzawa K
    Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):863-7. PubMed ID: 8645169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretion of endothelin converting enzyme-1a: the hydrophobic signal anchor domain alone is not sufficient to promote membrane localization.
    Brooks SC; Fernandez L; Ergul A
    Mol Cell Biochem; 2000 May; 208(1-2):45-51. PubMed ID: 10939627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure activity relationship of phosphoramidon derivatives for in vivo endothelin-converting-enzyme inhibition.
    Bigaud M; Hauss B; Schalk C; Jauch MF; D'Orchymont H
    Fundam Clin Pharmacol; 1994; 8(2):155-61. PubMed ID: 8020872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two di-leucine-based motifs account for the different subcellular localizations of the human endothelin-converting enzyme (ECE-1) isoforms.
    Valdenaire O; Barret A; Schweizer A; Rohrbacher E; Mongiat F; Pinet F; Corvol P; Tougard C
    J Cell Sci; 1999 Sep; 112 Pt 18():3115-25. PubMed ID: 10462527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble human endothelin-converting enzyme-1: expression, purification, and demonstration of pronounced pH sensitivity.
    Ahn K; Herman SB; Fahnoe DC
    Arch Biochem Biophys; 1998 Nov; 359(2):258-68. PubMed ID: 9808768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A three-dimensional model of endothelin-converting enzyme (ECE) based on the X-ray structure of neutral endopeptidase 24.11 (NEP).
    Bur D; Dale GE; Oefner C
    Protein Eng; 2001 May; 14(5):337-41. PubMed ID: 11438756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pharmacology of endothelin converting enzymes.
    Turner AJ; Murphy LJ
    Biochem Pharmacol; 1996 Jan; 51(2):91-102. PubMed ID: 8615890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential structure-activity relationships of phosphoramidon analogues for inhibition of three metalloproteases: endothelin-converting enzyme, neutral endopeptidase, and angiotensin-converting enzyme.
    Kukkola PJ; Savage P; Sakane Y; Berry JC; Bilci NA; Ghai RD; Jeng AY
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S65-8. PubMed ID: 8587470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evolutionarily conserved tripartite tryptophan motif stabilizes the prodomains of cathepsin L-like cysteine proteases.
    Kreusch S; Fehn M; Maubach G; Nissler K; Rommerskirch W; Schilling K; Weber E; Wenz I; Wiederanders B
    Eur J Biochem; 2000 May; 267(10):2965-72. PubMed ID: 10806395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of neutral endopeptidase-24.11 (neprilysin) and endothelin-converting enzyme in human prostate cancer cell lines.
    Usmani BA; Harden B; Maitland NJ; Turner AJ
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():314S-317S. PubMed ID: 12193112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of endothelin-converting enzyme-2. Implication for a role in the nonclassical processing of regulatory peptides.
    Mzhavia N; Pan H; Che FY; Fricker LD; Devi LA
    J Biol Chem; 2003 Apr; 278(17):14704-11. PubMed ID: 12560336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the hydrophobic transmembrane domain in membrane anchoring of endothelin-converting enzyme-1a.
    Brooks SC; Ergul A
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S30-2. PubMed ID: 11078328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of human endothelin-converting enzyme I complexed with phosphoramidon.
    Schulz H; Dale GE; Karimi-Nejad Y; Oefner C
    J Mol Biol; 2009 Jan; 385(1):178-87. PubMed ID: 18992253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.